Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-13

Clinical Trial Update: Testing How the Body Responds to the Drug CBX-12 in Patients With Advanced Solid Cancers [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating CBX-12 in adults with advanced solid tumors, including metastatic disease, is currently recruiting. The study aims to assess s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CBX-12

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm | Phase 1 | Status: RECRUITING